Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between road traffic accidents and drugs belonging to the antiseizure medications class: A pharmacovigilance analysis in VigiBase.
Chrétien B, Nguyen S, Dolladille C, Morice PM, Heraudeau M, Loilier M, Fedrizzi S, Bourgine J, Cesbron A, Alexandre J, Bocca ML, Freret T, Lelong-Boulouard V. Chrétien B, et al. Br J Clin Pharmacol. 2023 Jan;89(1):222-231. doi: 10.1111/bcp.15481. Epub 2022 Aug 21. Br J Clin Pharmacol. 2023. PMID: 35939367 Free article.
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization's database.
Prevost R, Chretien B, Minoc EM, Dolladille C, Da-Silva A, Nehme A, Joly F, Lelong-Boulouard V, Bastien E. Prevost R, et al. Among authors: chretien b. Front Pharmacol. 2023 Oct 20;14:1278682. doi: 10.3389/fphar.2023.1278682. eCollection 2023. Front Pharmacol. 2023. PMID: 37927591 Free PMC article.
Clinically significant drug-drug interactions between tramadol and CYP3A4 inhibitors: disproportionality analysis in VigiBase® and hypothesis on the underlying mechanism.
Delafoy C, Dolladille C, Besnier P, Sassier M, Bourgine J, Lelong-Boulouard V, Alexandre J, Guillaume C, Fedrizzi S, Chrétien B. Delafoy C, et al. Among authors: chretien b. Eur J Clin Pharmacol. 2020 Jul;76(7):1049-1051. doi: 10.1007/s00228-020-02881-5. Epub 2020 May 2. Eur J Clin Pharmacol. 2020. PMID: 32361903 No abstract available.
Rivaroxaban-induced hair loss.
Chrétien B, Besnard A, Sassier M, Le Hello C, Coquerel A, Alexandre J, Fedrizzi S. Chrétien B, et al. Eur J Clin Pharmacol. 2015 Nov;71(11):1413-4. doi: 10.1007/s00228-015-1927-7. Epub 2015 Aug 25. Eur J Clin Pharmacol. 2015. PMID: 26300206 No abstract available.
54 results